The short version of Nuclear receptor fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-10-31 and is reviewed periodically as new material appears.
GW501516 acts as an agonist at the peroxisome proliferator-activated receptor delta, a nuclear receptor that regulates gene expression. Activation shifts transcription toward genes involved in fatty acid uptake, oxidation, and energy expenditure. The compound does not bind the androgen receptor and therefore differs from anabolic steroids and SARMs. In rodent models, this metabolic shift has been linked to increased running endurance and reduced fat accumulation. The exact downstream pathways in humans remain incompletely characterized.
Early clinical research explored GW501516 for lipid disorders, obesity, and diabetes. Some short-term human studies reported changes in HDL cholesterol, LDL cholesterol, and triglycerides. The development program was discontinued after rodent studies showed dose-dependent tumor formation in multiple tissues, including liver, bladder, stomach, and skin. These findings raised concerns about long-term cancer risk in humans. Because human exposure data are limited, the clinical significance of the rodent tumors remains uncertain.
Literature on cardarine often separates receptor pharmacology from toxicology. Mechanistic papers describe PPARδ activation and gene expression changes, while safety assessments focus on carcinogenicity and species differences. Questions remain about whether rodent tumors arise through PPARδ-dependent or off-target mechanisms. Another open area is how human metabolism and exposure compare with those in animal studies. Analytical methods such as liquid chromatography–mass spectrometry are used to confirm identity in biological and product samples.
Cardarine is a common name for GW501516, a synthetic compound studied for its effects on lipid and glucose metabolism. It functions as an agonist at peroxisome proliferator-activated receptor delta, or PPARδ, a nuclear receptor that influences gene expression. The molecule is not a steroid, nor is it a selective androgen receptor modulator. It is also known in research and sports literature as GW-501516 and endurobol. Early laboratory work examined its metabolic activity in cell cultures and animal models.
Activation of PPARδ changes transcription of genes involved in fatty acid transport, mitochondrial function, and skeletal muscle fuel preference. In rodent studies, pharmacological PPARδ activation was associated with increased endurance and altered body composition. These findings generated interest in performance enhancement, but species differences and study designs limit direct extrapolation to humans. Small human trials were conducted in the 2000s and later discontinued. The extent to which cardarine produces similar metabolic or performance effects in people remains an open question.
| Property | Value | Notes |
|---|---|---|
| Primary target | PPARδ | Nuclear receptor; not androgen receptor |
| Studied indications | Dyslipidemia; obesity; diabetes | Early clinical research; development discontinued |
| Rodent toxicity | Tumor formation in multiple tissues | Dose-dependent findings in some studies |
| Human approval | None | No approved therapeutic use |
| Typical analytical method | LC-MS/MS | Used for identity and quantification |
Laboratory studies have examined GW501516 in cell cultures and rodents for conditions such as dyslipidemia, insulin resistance, and obesity. Some trials in humans were initiated, but development was discontinued after preclinical findings raised concerns about cancer in certain models. Those findings do not prove that the compound causes cancer in people, but they contributed to regulatory caution. Later reviews often describe the evidence as preliminary and insufficient for assessing long-term safety.
In the fitness and bodybuilding literature, cardarine is frequently discussed as an endurance agent or fat-loss compound, although such claims are not supported by robust clinical evidence. Online descriptions often mix animal data, user anecdotes, and marketing language. Researchers who study PPARδ agonists distinguish between receptor activation in controlled experiments and unsupervised use of unverified products. The latter introduces unknown purity, dose, and interactions, making reported experiences difficult to interpret scientifically.
Published literature on cardarine includes in vitro assays, rodent experiments, and a small number of human studies. Reports describe effects on exercise capacity and lipid metabolism in animals, while human evidence is sparse. Many online descriptions present the compound as a proven endurance aid, a claim not supported by regulatory approval or large clinical trials. Analytical studies focus on identifying the parent compound and its metabolites in biological samples. Important uncertainties include species differences, dose-response relationships, and the relevance of rodent tumor findings to humans.
Cardarine is the common name for GW501516, a synthetic compound studied as a peroxisome proliferator-activated receptor delta agonist. Researchers developed it to explore treatments for lipid disorders and metabolic conditions. It is not an approved medicine in any country. Early clinical work examined changes in HDL cholesterol and triglycerides, but development was discontinued after animal studies raised concerns about cancer. The compound remains available as a research chemical and appears in discussions of performance enhancement.
At the molecular level, GW501516 binds and activates PPARδ, a nuclear receptor that regulates transcription. Activation shifts expression of genes involved in fatty acid oxidation, energy expenditure, and lipid transport in skeletal muscle and liver. Animal studies report increased endurance and altered lipid profiles after exposure. Human data are limited to small trials and do not establish long-term safety or efficacy. PPARδ also has roles in cell proliferation, so the relationship between activation and cancer risk remains an open question.
A common misconception is that cardarine has been proven safe for human use. In reality, human clinical data are limited, and long-term animal studies have raised concerns about cancer. Another misconception is that it is a supplement or vitamin-like compound. It is a synthetic research chemical with no approved medical indication. Scientific discussion often focuses on its mechanism and detection rather than therapeutic use. Regulatory and anti-doping literature treats it primarily as a prohibited substance.
Cardarine is explicitly prohibited by the World Anti-Doping Agency under the class of PPARδ agonists. Its presence in urine or blood samples can be detected using mass spectrometry-based methods, often liquid chromatography-tandem mass spectrometry. Athletes who test positive may face sanctions, including bans from competition. The compound is also regulated as a prescription-only or unapproved drug in many countries. Enforcement varies by jurisdiction, and some regions treat it as a controlled substance. Online sales may occur despite these restrictions, creating quality and legal risks.
==== Prophecies and statements ==== In 2013, Bakker wrote Time Has Come: How to Prepare Now for Epic Events Ahead about end-time events. Bakker has changed his views on prosperity theology. In his 1980 book Eight Keys to Success, he stated, "God wants you to be happy, God wants you to be rich, God wants you to prosper." In his 1996 book, I Was Wrong, he admitted that the first time he actually read the Bible all the way through was in prison. Bakker also wrote that he realized that he had taken passages out of context and used them as prooftexts to support his prosperity theology. Bakker's revived show features a number of ministers who bill themselves as "prophets". He now says that "PTL" stands for "Prophets Talking Loud". In an October 2017 video, Bakker said that "God will punish those" who ridicule him; he has said that Hurricane Harvey was a judgment of God, and he blamed Hurricane Matthew on then-President Barack Obama. Bakker predicted that if then-President Donald Trump was impeached, Christians would begin a Second American Civil War. He compared the 2017 Washington train derailment to the sinking of the RMS Titanic and stated the Amtrak train derailment was a warning from God. He also claimed that he predicted the September 11 attacks of 2001, stating that he "saw 9/11 in 1999 before New Year's Eve" and that there would "be terrorism" and bombings in New York City and Washington, D.C. A few days after the Stoneman Douglas High School shooting, he stated that "God came to [him] in a dream...
== Practical applications == With the human genome sequenced, the next step is the verification and functional annotation of all predicted genes and their protein products. Shotgun proteomics can be used for functional classification or comparative analysis of these protein products. It can be used in projects ranging from large-scale whole proteome to focusing on a single protein family. It can be done in research labs or commercially.
=== Coiled coil filament === To improve the efficiency of the lamp, the filament usually consists of multiple coils of coiled fine wire, also known as a coiled coil. Light bulbs using coiled coil filaments are sometimes referred to as double-coil bulbs. For a 60-watt 120-volt lamp, the uncoiled length of the tungsten filament is usually 580 millimetres (22.8 in), and the filament diameter is 0.046 millimetres (0.0018 in). The advantage of the coiled coil is that there is less flow of gas in the bulb along the surface of the filament wire itself. Instead, gas only flows around the outside of whole coiled coil form, reducing both evaporation of the material and heat loss from the wire. The coiled-coil filament evaporates more slowly than a straight filament of the same surface area and light-emitting power, meaning the bulb lasts longer. The increased heat retained in the filament means that it runs hotter, which results in a more efficient light source.
Sources: en.wikipedia.org
== Properties == N-Hydroxyphthalimide exists in two polymorphs, colorless and yellow, In the colorless white form, the NOH group is rotated about 1.19° from the plane of the molecule, while in the yellow form it is much closer to planarity (0.06° rotation). The color of the synthesized N-hydroxyphthalimide is determined by the solvent used; the color transition from white to yellow is irreversible. N-Hydroxyphthalimide forms strongly colored, mostly yellow or red salts with alkali and heavy metals, ammonia and amines. Hydrolysis of N-hydroxyphthalimide by the addition of strong bases produces phthalic acid monohydroxamic acid by adding water across one of the carbon–nitrogen bonds. N-Hydroxyphthalimide ethers, on the other hand, are colorless and provide O-alkylhydroxylamines by alkaline hydrolysis or cleavage through hydrazine hydrate. The "phthalylhydroxylamine" reported by Cohn was known to have a molecular formula of C8H5NO3, but the exact structure was not known. Three possibilities were discussed and are shown in the Figure below: a mono-oxime of phthalic anhydride ("phthaloxime", I), an expanded ring with two heteroatoms, (2,3-benzoxazine-1,4-dione, II), and N-hydroxyphthalimide (III). It was not until the 1950s that Cohn's product was definitely shown to be N-hydroxyphthalimide (III).
The genes responsible for the conversion of (S) -reticuline to noscapine are found on chromosome 11. The genes responsible for the conversion of (S) -reticuline to thebaine are found on chromosome 11. The genes responsible for the conversion of thebaine are found in chromosome 1, chromosome 2, chromosome 7, and perhaps others.
== Medical uses == In the European Union, metreleptin is indicated in addition to diet to treat lipodystrophy, where people have a loss of fatty tissue under the skin and a build-up of fat elsewhere in the body such as in the liver and muscles. It is used in adults and children above the age of two years with generalized lipodystrophy (Berardinelli–Seip syndrome and Lawrence syndrome); and in adults and children above the age of twelve years with partial lipodystrophy (including Barraquer–Simons syndrome), when standard treatments have failed. In the United States, it is indicated as an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in people with congenital or acquired generalized lipodystrophy.
Serotonin taken orally does not pass into the serotonergic pathways of the central nervous system, because it does not cross the blood–brain barrier. However, tryptophan and its metabolite 5-hydroxytryptophan (5-HTP), from which serotonin is synthesized, do cross the blood–brain barrier. These agents are available as dietary supplements and in various foods, and may be effective serotonergic agents. One product of serotonin breakdown is 5-hydroxyindoleacetic acid (5-HIAA), which is excreted in the urine. Serotonin and 5-HIAA are sometimes produced in excess amounts by certain tumors or cancers, and levels of these substances may be measured in the urine to test for these tumors.
Sources: en.wikipedia.org
== Awards == Twin Peaks won a 2010 Hot Concept award from Nation's Restaurant News. In 2011, Twin Peaks was named "Franchisee of the Year" by the International Franchise Association at their annual conference in Washington, D.C. Twin Peaks was named number 1 in Knapp Track for comp sales in 2017 among all casual dining brands. In 2017, Twin Peaks was named a winner in the Enterprise Innovator category at the 2017 MURTEC (Multi-Unit Restaurant Technology Conference). In 2018, Twin Peaks was ranked number 196 on the Franchise Times top 200 list.
The term ratfucking is a slang term used by U.S. military personnel to describe the targeted pillaging of MREs, which is not to be confused with "field stripping". It refers to the process of opening a case of MREs (which are packed 12 in a box), opening up individual MRE packages, removing the desired items, and leaving the unenticing remainder. This is in reference to the ratlike nature of the act, as of a rodent infesting an area and consuming the desirable resources. The undesirables are then placed into another MRE box, commonly referred to as the "ratfuck box".
In November 2023, the two debated, with Fox News's Sean Hannity as moderator. In July 2024, Newsom launched a podcast, Politickin', co-hosted by Marshawn Lynch and Doug Hendrickson. After Biden's sudden withdrawal from the presidential race that month, Newsom said he would not seek the Democratic nomination, and endorsed Vice President Kamala Harris for president. After Donald Trump won the 2024 election, Newsom called for California lawmakers to convene later in 2024 to safeguard California's policies from the second Trump administration. In December 2024, Newsom criticized Biden for pardoning his son Hunter, saying, "I'm disappointed and can't support the decision." Since the 2024 U.S. presidential election, Newsom has repeatedly declined to identify himself with either the progressive or moderate faction of the Democratic Party, calling such labels "reductive" and calling himself a "hard-headed pragmatist". He said he wants the Democratic Party to be an "inclusive" big tent, spanning the ideological spectrum "from Manchin to Mamdani". In August 2025, Newsom began communicating on social media platforms in a style intended to mock Trump's style of online communication. In June 2026, Newsom said the United States Department of Justice was prosecuting him and his wife at Trump's direction.
A Broadway production named Shining City was Platt's Broadway debut in 2006. The play was set in Dublin, and Platt's role was the tortured protagonist, John. Shining City's director said, "There is one word to describe Oliver. It's 'humanity.' He's got that everyman quality. He's a contradictory human being with flaws and strengths. And he's loveable. He can simultaneously make you laugh and break your heart. Oliver has brought to the role of John what I expected and more: tremendous inventiveness and sensitivity." Platt visited Dublin to prepare for the role and ensure his performance was authentic. He was nominated for a Tony Award for "Best Performance by a Leading Actor in a Play". In 2007, Platt played the part of Yankees owner George Steinbrenner in the ESPN mini-series The Bronx Is Burning. Platt signed onto the project after John Turturro was confirmed as Billy Martin, because "This thing lives or dies by that portrayal ... I think it's great casting. God knows he has the intensity." Platt starred in the pilot episode of The Thick of It, a remake of the British show of the same name in 2007. The series was not picked up by ABC. Platt starred as Nathan Detroit, alongside Lauren Graham as Miss Adelaide, in the Broadway revival of Guys and Dolls which began performances at the Nederlander Theatre on February 3, 2009, and officially opened on March 1, 2009. The production closed on June 14, 2009, after 113 performances. Platt starred as White House Chief of Staff Carl Anheuser in Roland Emmerich's 2012, a disaster film released November 13, 2009.
Her two manuscripts on form A DNA reached Acta Crystallographica in Copenhagen on 6 March 1953, one day before Crick and Watson had completed their model. The X-ray diffraction images collected by Gosling and Franklin provided the best evidence for the helical nature of DNA. Before this, both Linus Pauling, Watson, and Crick had generated erroneous models with the chains inside and the bases pointing outwards. Her experimental results provided estimates of the water content of DNA crystals, and these results were most consistent with the three sugar-phosphate backbones being on the outside of the molecule. Franklin's X-Ray photograph showed that the backbones had to be on the outside. Although she at first insisted vehemently that her data did not force one to conclude that DNA has a helical structure, in the drafts she submitted in 1953 she argues for a double helical DNA backbone. Building on her manuscripts, she discovered that form A DNA had antiparallel backbones, which supported the double helical structure of DNA. She did this through identification of the space group for DNA crystals. This would go to help Watson and Crick decide to look for DNA models with two antiparallel polynucleotide strands. In summary, Watson and Crick had three sources for Franklin's unpublished data: 1) her 1951 seminar, attended by Watson, 2) discussions with Wilkins, who worked in the same laboratory with Franklin, 3) a research progress report that was intended to promote coordination of Medical Research Council–supported laboratories.
Sources: en.wikipedia.org
It targets PPARδ, a nuclear receptor involved in lipid and energy metabolism. It does not act primarily on androgen receptors. This distinction separates it from SARMs.
Rodent studies found dose-dependent tumors in several organs. The sponsor discontinued the program over cancer concerns. Human risk from long-term use remains unknown.
Controlled human endurance trials are lacking. Animal studies show increased exercise capacity under some conditions. Anecdotal reports are not equivalent to clinical evidence.
Cardarine is a common name for GW501516, a synthetic PPARδ agonist. It is not a steroid or a selective androgen receptor modulator. It was developed and studied as a research compound for metabolic pathways.